• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒整合驱动隐匿性乙型肝炎感染期间的多灶性 HCC。

Viral integration drives multifocal HCC during the occult HBV infection.

机构信息

The Hepatic Surgery Centre at Tongji Hospital, Tongji Medical College, HUST; Hubei Province for the Clinical Medicine Research Center of Hepatic Surgery, Key Laboratory of Organ Transplantation, Ministry of Education and Ministry of Public Health, Wuhan, 430030, China.

Department of Computer Science, City University of Hong Kong, Hong Kong, People's Republic of China.

出版信息

J Exp Clin Cancer Res. 2019 Jun 14;38(1):261. doi: 10.1186/s13046-019-1273-1.

DOI:10.1186/s13046-019-1273-1
PMID:31200735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6570863/
Abstract

BACKGROUND & AIMS: Although the prognosis of patients with occult hepatitis B virus (HBV) infection (OBI) is usually benign, a small portion may undergo cirrhosis and subsequently hepatocellular carcinoma (HCC). We studied the mechanism of life-long Integration of virus DNA into OBI host's genome, of which may induce hepatocyte transformation.

METHODS

We applied HBV capture sequencing on single cells from an OBI patient who, developed multiple HCC tumors and underwent liver resection in May 2013 at Tongji Hospital in China. Despite with the undetectable virus DNA in serum, we determined the pattern of viral integration in tumor cells and adjacent non-tumor cells and obtained the details of the viral arrangement in host genome, and furthermore the HBV integrated region in cancer genome.

RESULTS

HBV captured sequencing of tissues and individual cells revealed that samples from multiple tumors shared two viral integration sites that could affect three host genes, including CSMD2 on chr1 and MED30/EXT1 on chr8. Whole genome sequencing further indicated one hybrid chromosome formed by HBV integrations between chr1 and chr8 that was shared by multiple tumors. Additional 50 poorly differentiated liver tumors and the paired adjacent non-tumors were evaluated and functional studies suggested up-regulated EXT1 expression promoted HCC growth. We further observed that the most somatic mutations within the tumor cell genome were common among the multiple tumors, suggesting that HBV associated, multifocal HCC is monoclonal in origin.

CONCLUSION

Through analyzing the HBV integration sites in multifocal HCC, our data suggested that the tumor cells were monoclonal in origin and formed in the absence of active viral replication, whereas the affected host genes may subsequently contribute to carcinogenesis.

摘要

背景与目的

尽管隐匿性乙型肝炎病毒(HBV)感染(OBI)患者的预后通常良好,但一小部分患者可能会发展为肝硬化,进而发展为肝细胞癌(HCC)。我们研究了病毒 DNA 终身整合到 OBI 宿主基因组中的机制,这可能会诱导肝细胞转化。

方法

我们对一名 OBI 患者的单个细胞进行了 HBV 捕获测序,该患者于 2013 年 5 月在中国同济医院接受了多次 HCC 肿瘤切除术和肝切除术。尽管血清中无法检测到病毒 DNA,但我们确定了肿瘤细胞和相邻非肿瘤细胞中病毒整合的模式,并获得了宿主基因组中病毒排列的详细信息,以及癌症基因组中 HBV 整合区域的详细信息。

结果

组织和单个细胞的 HBV 捕获测序显示,多个肿瘤的样本共享两个可能影响三个宿主基因的病毒整合位点,包括 chr1 上的 CSMD2 和 chr8 上的 MED30/EXT1。全基因组测序进一步表明,chr1 和 chr8 之间的 HBV 整合形成了一条共享的杂合染色体,该染色体存在于多个肿瘤中。另外 50 个低分化肝癌及配对的相邻非肿瘤组织进行了评估,功能研究表明,EXT1 表达上调促进了 HCC 的生长。我们进一步观察到,肿瘤细胞基因组中大多数体细胞突变在多个肿瘤中是共同存在的,这表明 HBV 相关的多灶性 HCC 起源于单克隆。

结论

通过分析多灶性 HCC 中的 HBV 整合位点,我们的数据表明肿瘤细胞起源于单克隆,并且在没有活跃病毒复制的情况下形成,而受影响的宿主基因可能随后有助于癌变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4c84655d2352/13046_2019_1273_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/5e1b5fbd2014/13046_2019_1273_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4b7e8cf3e636/13046_2019_1273_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4048d6a3adfa/13046_2019_1273_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/f36420add587/13046_2019_1273_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/20b9cacd70ce/13046_2019_1273_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4c84655d2352/13046_2019_1273_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/5e1b5fbd2014/13046_2019_1273_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4b7e8cf3e636/13046_2019_1273_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4048d6a3adfa/13046_2019_1273_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/f36420add587/13046_2019_1273_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/20b9cacd70ce/13046_2019_1273_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d0/6570863/4c84655d2352/13046_2019_1273_Fig6_HTML.jpg

相似文献

1
Viral integration drives multifocal HCC during the occult HBV infection.病毒整合驱动隐匿性乙型肝炎感染期间的多灶性 HCC。
J Exp Clin Cancer Res. 2019 Jun 14;38(1):261. doi: 10.1186/s13046-019-1273-1.
2
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).HBV 基因组富集单细胞测序揭示了 HBV 驱动的肝细胞癌 (HCC) 的异质性。
BMC Med Genomics. 2022 Jun 16;15(1):134. doi: 10.1186/s12920-022-01264-2.
3
Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.在乙型肝炎表面抗原检测不到的肝癌患者中,很大一部分存在 HBV DNA 整合到肝细胞 DNA 中而无肝硬化。
Clin Gastroenterol Hepatol. 2020 Feb;18(2):449-456. doi: 10.1016/j.cgh.2019.06.029. Epub 2019 Jun 25.
4
Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.非侵入性嵌合 DNA 分析鉴定了导致肝癌中病毒抗原表达的源自肿瘤的 HBV 整合体。
Hepatol Int. 2020 May;14(3):326-337. doi: 10.1007/s12072-020-10016-2. Epub 2020 Feb 25.
5
Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.日本肝癌患者中隐匿性乙型肝炎感染的频率和特征。
Ann Hepatol. 2018;17(4):596-603. doi: 10.5604/01.3001.0012.0927.
6
A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.一项关于低程度和高程度肝纤维化的乙肝病毒相关肝细胞癌复发风险的试点系统性基因组比较。
BMC Med. 2017 Dec 7;15(1):214. doi: 10.1186/s12916-017-0973-7.
7
Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.乙型肝炎病毒整合在肝癌基因组中的特征。
Viruses. 2021 Feb 4;13(2):245. doi: 10.3390/v13020245.
8
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.隐匿性乙型肝炎感染与肝细胞癌:流行病学、病毒学、肝癌发生机制及临床意义。
J Hepatol. 2020 Oct;73(4):952-964. doi: 10.1016/j.jhep.2020.05.042. Epub 2020 Jun 3.
9
Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.乙型肝炎病毒相关肝细胞癌中肿瘤与病毒基因组特征的整合
Gut. 2015 May;64(5):820-9. doi: 10.1136/gutjnl-2013-306228. Epub 2014 Jun 9.
10
Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.AAV2 和乙型肝炎病毒整合到基因组中对既往乙型肝炎病毒感染患者肝细胞癌发展的影响。
Clin Cancer Res. 2019 Oct 15;25(20):6217-6227. doi: 10.1158/1078-0432.CCR-18-4041. Epub 2019 Jul 18.

引用本文的文献

1
HBV DNA integration gene CCDC91 is oncogenic and a potential therapeutic target for hepatocellular carcinoma.乙肝病毒DNA整合基因CCDC91具有致癌性,是肝细胞癌的一个潜在治疗靶点。
Commun Biol. 2025 Jul 20;8(1):1079. doi: 10.1038/s42003-025-08369-1.
2
Potential Roles of Serum Exosomal CD155 and its Impact on NK Cell Immunosuppression in Hepatocellular Carcinoma.血清外泌体CD155在肝细胞癌中的潜在作用及其对自然杀伤细胞免疫抑制的影响
Balkan Med J. 2025 May 5;42(3):242-253. doi: 10.4274/balkanmedj.galenos.2025.2025-1-129.
3
Detection technology and clinical applications of serum viral products of hepatitis B virus infection.

本文引用的文献

1
Occult hepatitis B infection.隐匿性乙型肝炎感染
J Hepatol. 2014 Sep;61(3):688-9. doi: 10.1016/j.jhep.2014.04.036. Epub 2014 Jun 26.
2
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.转录中介因子 1γ表达降低促进肝癌转移并预示不良预后。
Hepatology. 2014 Nov;60(5):1620-36. doi: 10.1002/hep.27273. Epub 2014 Sep 25.
3
Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.CSMD1或CSMD2的缺失可能导致结直肠癌患者预后不良。
乙型肝炎病毒感染血清病毒产物的检测技术及其临床应用。
Front Cell Infect Microbiol. 2024 Jul 5;14:1402001. doi: 10.3389/fcimb.2024.1402001. eCollection 2024.
4
Prevalence of Hepatocellular Carcinoma in Hepatitis B Population within Southeast Asia: A Systematic Review and Meta-Analysis of 39,050 Participants.东南亚乙肝人群中肝细胞癌的患病率:对39,050名参与者的系统评价和荟萃分析
Pathogens. 2023 Oct 6;12(10):1220. doi: 10.3390/pathogens12101220.
5
HBV-integrated local genomic alterations reveal multicentric independent occurrences of multifocal HCC.乙肝病毒整合的局部基因组改变揭示了多灶性肝癌的多中心独立发生情况。
Clin Transl Med. 2023 Jun;13(6):e1313. doi: 10.1002/ctm2.1313.
6
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.用于预测肝细胞癌预后和治疗结果的肿瘤突变负荷
Int J Mol Sci. 2023 Feb 8;24(4):3441. doi: 10.3390/ijms24043441.
7
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure.乙肝病毒DNA整合作为乙肝病毒介导的致病特性的新型生物标志物以及乙肝病毒治愈当前策略的障碍。
Front Microbiol. 2022 Sep 2;13:972687. doi: 10.3389/fmicb.2022.972687. eCollection 2022.
8
Occult Hepatitis B Virus Infection: An Update.隐匿性乙型肝炎病毒感染:最新研究进展。
Viruses. 2022 Jul 8;14(7):1504. doi: 10.3390/v14071504.
9
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).HBV 基因组富集单细胞测序揭示了 HBV 驱动的肝细胞癌 (HCC) 的异质性。
BMC Med Genomics. 2022 Jun 16;15(1):134. doi: 10.1186/s12920-022-01264-2.
10
Single-Cell Sequencing and Its Applications in Liver Cancer.单细胞测序及其在肝癌中的应用
Front Oncol. 2022 Apr 21;12:857037. doi: 10.3389/fonc.2022.857037. eCollection 2022.
Tumour Biol. 2014 May;35(5):4419-23. doi: 10.1007/s13277-013-1581-6. Epub 2014 Jan 10.
4
Single-cell paired-end genome sequencing reveals structural variation per cell cycle.单细胞双端基因组测序揭示了每个细胞周期的结构变异。
Nucleic Acids Res. 2013 Jul;41(12):6119-38. doi: 10.1093/nar/gkt345. Epub 2013 Apr 29.
5
Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.鉴定能够增强肝癌细胞对干扰素-α/5-氟尿嘧啶敏感性的基因及其临床意义。
PLoS One. 2013;8(2):e56197. doi: 10.1371/journal.pone.0056197. Epub 2013 Feb 15.
6
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: insights from next generation DNA sequencing.伴有门静脉癌栓的晚期乙肝相关肝细胞癌的基因改变:来自二代DNA测序的见解
J Hepatol. 2013 May;58(5):1042-4. doi: 10.1016/j.jhep.2012.11.046. Epub 2012 Dec 6.
7
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关性肝细胞癌的外显子组测序。
Nat Genet. 2012 Oct;44(10):1117-21. doi: 10.1038/ng.2391. Epub 2012 Aug 26.
8
Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.精 needle aspiration 标本中,Arginase-1、HepPar-1 和 Glypican-3 是区分肝细胞癌和转移性肿瘤的最有效 panel 标志物。
Am J Clin Pathol. 2012 Aug;138(2):203-10. doi: 10.1309/AJCPK1ZC9WNHCCMU.
9
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.全基因组范围内检测肝细胞癌中 HBV 的反复整合。
Nat Genet. 2012 May 27;44(7):765-9. doi: 10.1038/ng.2295.
10
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm.单细胞外显子组测序和 JAK2 阴性骨髓增殖性肿瘤的单克隆进化。
Cell. 2012 Mar 2;148(5):873-85. doi: 10.1016/j.cell.2012.02.028.